Li et al. showed that senescence of myeloid-derived suppressor cells (MDSCs) promoted the pathogenesis of SLE, while dihydroartemisinin alleviated the manifestation of SLE by attenuating MDSC senescence via regulating Nrf2/HO-1 pathway (54). Here, HMOX1 is linked to systemic lupus erythematosus.